Clinical trial · Interventional
The Effect of Oral Care Protocol on Prevention of Oral Mucositis in Pediatric Cancer Patients
NCT04586491CI-TRIAL-00047696completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study conducted to determine the effects of two oral care protocols containing sodium bicarbonate or saline solution in the prevention of oral mucositis (OM), mucositis degree, and recovery time in children with cancer.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Mucositis | — | UNRESOLVED | — |
| Oral Cavity | — | UNRESOLVED | — |
| Pediatric Cancer | Childhood Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Oral care protocol | Combination Product | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Study group/ Oral care protocol with saline solution
- description
- All patients took oral care protocol in the unit with saline solution
- interventionNames
- Combination Product: Oral care protocol
- type
- EXPERIMENTAL
- label
- Control group/ Oral care protocol with sodium bicarbonate solution
- description
- All patients took oral care protocol in the unit with sodium bicarbonate solution
- interventionNames
- Combination Product: Oral care protocol
Primary outcomes (1)
- measure
- development of oral mucositis
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Year
- Maximum age
- 17 Years
Show eligibility criteria text
Inclusion Criteria: * have cancer, aged 1-17 years, received chemotherapy for ≥3 days at inpatient clinics and whose families agreed to their participation in the study. Exclusion Criteria: * who have oral ulceration or mucositis, in terminal period, taking any antiviral or antifungal therapy for OM before enrollment in the study.
References
Publications (0)
Data not yet available
No reference posted for this study.